KDM2AFYN

Yuzhou Xue1,2, Yuce Peng2, Ling Jin1

  • 1Department of Cardiology and Institute of Vascular Medicine, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Third Hospital, Beijing, China.

概括

KDM2A是动脉样硬化中巨细胞炎症的关键调节剂. 针对KDM2A及其下游目标FYN,为治疗动脉样硬化提供了一个有前途的治疗策略.